Recent Updates
Recently added Catalysts
PRGO Positive Sentiment Score: 70/100

Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025

Key Takeaway: Perrigo Company plc has announced the release date for its third quarter 2025 financial results, which will be available on November 5, 2025. The company will host a conference call at 8:30 A.M. (EST) to discuss these results, accessible via webcast and phone. A replay of the call will be available for a limited time after the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Perrigo is set to release its financial results, indicating ongoing business activity.
  • The company continues to engage with investors through a scheduled conference call.
  • Perrigo's long history in self-care products showcases its stability and market presence.

Full Press Release Details

DUBLIN,Oct. 22, 2025/PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading provider ofConsumer Self-Care Products,today announced that it plans to issue its third quarter 2025 financial results on Wednesday, November 5th, 2025, and host a conference call beginning at 8:30 A.M. (EST).
The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website athttp://perrigo.investorroom.com/events-webcastsor by phone at 800-836-8184, International 646-357-8785, and reference ID # 03742. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday, November 5, until midnight Wednesday, November 12, 2025. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 03742#.

About Perrigo

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, includingOpill®, Mederma®, Compeed®, EllaOne®,andJungle Formula®.
For more information, visitwww.perrigo.com.

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available athttps://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024.

Perrigo Contact

Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail:[email protected]
Nicholas Gallagher, Associate Director, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail:[email protected]
SOURCE Perrigo Company plc

Frequently Asked Questions

When will Perrigo release its Q3 2025 financial results?

Perrigo will release its Q3 2025 financial results on November 5, 2025.

What time is the conference call for Q3 results?

The conference call will begin at 8:30 A.M. (EST) on November 5, 2025.

How can I access the conference call?

The conference call can be accessed via webcast or by phone at 800-836-8184.

Will there be a replay of the conference call?

Yes, a replay will be available from 12:00 P.M. (EST) on November 5 until midnight on November 12, 2025.

Last updated: Oct 22, 2025